BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8467429)

  • 1. Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
    Raghavan R; Khin-Nu C; Brown A; Irving D; Ince PG; Day K; Tyrer SP; Perry RH
    Can J Neurol Sci; 1993 Feb; 20(1):48-51. PubMed ID: 8467429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):193-200. PubMed ID: 2539435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down's syndrome and Parkinson's disease.
    Hestnes A; Daniel SE; Lees AJ; Brun A
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):289. PubMed ID: 9069490
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.
    Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ
    Ann Neurol; 1999 Mar; 45(3):353-7. PubMed ID: 10072050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():125-35. PubMed ID: 2411933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):341-4. PubMed ID: 2951499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
    Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):972-5. PubMed ID: 1800669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
    Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
    Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
    Mann DM; Yates PO; Marcyniuk B
    Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.